{
    "Alzheimer's_disease": {
        "CMAP": {
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": 0.100487784857542,
                    "p": 0.48654,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.120175446732561,
                    "p": 0.42744,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": -0.149259156755915,
                    "p": 0.26028,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.169478518910167,
                    "p": 0.1507,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 58.0,
                    "cmap_score": -0.116131241686826,
                    "p": 0.4444,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.101422934537757,
                    "p": 0.48482,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.156886257841652,
                    "p": 0.21608,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 227.0,
                    "cmap_score": -0.135059761370652,
                    "p": 0.34801,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 390.0,
                    "cmap_score": -0.122865696732356,
                    "p": 0.41466,
                    "q": 0.977086486486487,
                    "subset_comparison_id": "filefb0210a2fb3_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            }
        }
    },
    "Asthma": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": -0.120030895644292,
                    "p": 0.43113,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 178.0,
                    "cmap_score": 0.0833389241083564,
                    "p": 0.50037,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.147633571225545,
                    "p": 0.27514,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.0886942046809364,
                    "p": 0.49885,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 403.0,
                    "cmap_score": -0.180106563541427,
                    "p": 0.10865,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.150237582378361,
                    "p": 0.25937,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.0943160047934951,
                    "p": 0.49553,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.138189246609882,
                    "p": 0.333,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 243.0,
                    "cmap_score": -0.167894958650091,
                    "p": 0.16179,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": -0.109900381964132,
                    "p": 0.4686,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": -0.15178708276791,
                    "p": 0.24983,
                    "q": 0.958470837004405,
                    "subset_comparison_id": "filefb03c9e9086_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Astrocytoma": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2529.0,
                    "cmap_score": -0.199479041489692,
                    "p": 0.04239,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000311",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2615.0,
                    "cmap_score": -0.138727141173728,
                    "p": 0.30996,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000861",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3458.0,
                    "cmap_score": -0.172966445017093,
                    "p": 0.12281,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000580",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4249.0,
                    "cmap_score": -0.154811719802134,
                    "p": 0.21332,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": NaN,
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8870.0,
                    "cmap_score": -0.197382364938361,
                    "p": 0.04669,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000750",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10972.0,
                    "cmap_score": -0.182277413757381,
                    "p": 0.08731,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000950",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12227.0,
                    "cmap_score": -0.140913394799544,
                    "p": 0.29665,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000311",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12348.0,
                    "cmap_score": -0.149595647078628,
                    "p": 0.24396,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000558",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12709.0,
                    "cmap_score": -0.192305792240754,
                    "p": 0.05832,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13107.0,
                    "cmap_score": -0.158382057391485,
                    "p": 0.19252,
                    "q": 0.836059801299675,
                    "subset_comparison_id": "filefb0291a7289_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Atherosclerosis": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": -0.127800277930283,
                    "p": 0.27584,
                    "q": 0.823032319391635,
                    "subset_comparison_id": "filefb07559574_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 29.0,
                    "cmap_score": -0.137272742576715,
                    "p": 0.21232,
                    "q": 0.823032319391635,
                    "subset_comparison_id": "filefb07559574_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 99.0,
                    "cmap_score": -0.142624448198694,
                    "p": 0.1782,
                    "q": 0.823032319391635,
                    "subset_comparison_id": "filefb07559574_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 206.0,
                    "cmap_score": -0.126215673465043,
                    "p": 0.28686,
                    "q": 0.823032319391635,
                    "subset_comparison_id": "filefb07559574_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": -0.118138019157531,
                    "p": 0.34493,
                    "q": 0.823032319391635,
                    "subset_comparison_id": "filefb07559574_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 343.0,
                    "cmap_score": -0.088766631423065,
                    "p": 0.48382,
                    "q": 0.823032319391635,
                    "subset_comparison_id": "filefb07559574_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": -0.127772718411225,
                    "p": 0.276,
                    "q": 0.823032319391635,
                    "subset_comparison_id": "filefb07559574_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": -0.116707096345363,
                    "p": 0.35463,
                    "q": 0.823032319391635,
                    "subset_comparison_id": "filefb07559574_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Autism_spectrum_disorder": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2529.0,
                    "cmap_score": -0.225369628261752,
                    "p": 0.02133,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000311",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2653.0,
                    "cmap_score": -0.223166914153721,
                    "p": 0.02367,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000681",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3588.0,
                    "cmap_score": -0.186480321606254,
                    "p": 0.10492,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "allantoin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000348",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4239.0,
                    "cmap_score": -0.210746998426236,
                    "p": 0.04088,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000790",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8947.0,
                    "cmap_score": -0.206102665879785,
                    "p": 0.04972,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": NaN,
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10985.0,
                    "cmap_score": -0.218061494187227,
                    "p": 0.02977,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12220.0,
                    "cmap_score": -0.202060837394659,
                    "p": 0.05851,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000750",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12437.0,
                    "cmap_score": -0.211418354655295,
                    "p": 0.03959,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000790",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12653.0,
                    "cmap_score": -0.237795905675703,
                    "p": 0.01197,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000222",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13048.0,
                    "cmap_score": -0.218766975073612,
                    "p": 0.02891,
                    "q": 0.991540978357545,
                    "subset_comparison_id": "filefb0136c55ae_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000558",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Bipolar_disorder": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 327.0,
                    "cmap_score": -0.145942662314572,
                    "p": 0.32071,
                    "q": 0.96021960199005,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": -0.132175832635308,
                    "p": 0.39641,
                    "q": 0.96021960199005,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.200139740663119,
                    "p": 0.07105,
                    "q": 0.96021960199005,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 93.0,
                    "cmap_score": -0.182903535211641,
                    "p": 0.12625,
                    "q": 0.96021960199005,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.135300626342832,
                    "p": 0.37974,
                    "q": 0.96021960199005,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.0881649356398444,
                    "p": 0.49778,
                    "q": 0.990993211009174,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": 0.116811105115329,
                    "p": 0.45878,
                    "q": 0.966555922330097,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 284.0,
                    "cmap_score": -0.15373454158717,
                    "p": 0.27428,
                    "q": 0.96021960199005,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 95.0,
                    "cmap_score": -0.200831422545248,
                    "p": 0.06901,
                    "q": 0.96021960199005,
                    "subset_comparison_id": "filefb02d6d1c78_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2420.0,
                    "cmap_score": -0.284419669210659,
                    "p": 0.00138,
                    "q": 0.427956226415094,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000396",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2616.0,
                    "cmap_score": -0.249084874135605,
                    "p": 0.00865,
                    "q": 0.559327142857143,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000148",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3559.0,
                    "cmap_score": -0.279564033774667,
                    "p": 0.00176,
                    "q": 0.428578255813953,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "allantoin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4213.0,
                    "cmap_score": -0.246582607733176,
                    "p": 0.00992,
                    "q": 0.559327142857143,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000997",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8882.0,
                    "cmap_score": -0.212385625737898,
                    "p": 0.04438,
                    "q": 0.632292514395394,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000853",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11000.0,
                    "cmap_score": -0.243611907572947,
                    "p": 0.01121,
                    "q": 0.559327142857143,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000555",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12273.0,
                    "cmap_score": -0.226918272474279,
                    "p": 0.02407,
                    "q": 0.581388240270728,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000601",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12434.0,
                    "cmap_score": -0.274936356257379,
                    "p": 0.00232,
                    "q": 0.428578255813953,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000139",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12719.0,
                    "cmap_score": -0.322128916132569,
                    "p": 0.00019,
                    "q": 0.351026,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000793",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13058.0,
                    "cmap_score": -0.25078599363299,
                    "p": 0.00797,
                    "q": 0.559327142857143,
                    "subset_comparison_id": "filefb056682194_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000120",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Breast_cancer": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2435.0,
                    "cmap_score": -0.213102442039649,
                    "p": 0.02767,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2585.0,
                    "cmap_score": -0.194782505254025,
                    "p": 0.05984,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3453.0,
                    "cmap_score": -0.19877297252004,
                    "p": 0.05084,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000681",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4282.0,
                    "cmap_score": -0.198044379149371,
                    "p": 0.05237,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000463",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8883.0,
                    "cmap_score": -0.170615546906768,
                    "p": 0.14403,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11049.0,
                    "cmap_score": -0.205720464477959,
                    "p": 0.03808,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000757",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12241.0,
                    "cmap_score": -0.210051795427186,
                    "p": 0.03158,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000437",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12386.0,
                    "cmap_score": -0.186446159705251,
                    "p": 0.08288,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000348",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12633.0,
                    "cmap_score": -0.16424581212935,
                    "p": 0.17389,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13081.0,
                    "cmap_score": -0.232758468844235,
                    "p": 0.01068,
                    "q": 0.994109866349866,
                    "subset_comparison_id": "filefb04cb8c668_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000628",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Chronic_granulomatous_disease": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.158701444325024,
                    "p": 0.13995,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": -0.173151723913132,
                    "p": 0.08219,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.151068036592147,
                    "p": 0.17946,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.154379840104464,
                    "p": 0.16181,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 58.0,
                    "cmap_score": -0.103556910864705,
                    "p": 0.45753,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.129172279566901,
                    "p": 0.31638,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.14319936105931,
                    "p": 0.22509,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 243.0,
                    "cmap_score": -0.119553641904837,
                    "p": 0.378,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": -0.0822368276772028,
                    "p": 0.49807,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.100884255037074,
                    "p": 0.46671,
                    "q": 0.85837652173913,
                    "subset_comparison_id": "filefb03c3ebabc_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2403.0,
                    "cmap_score": -0.176373820023961,
                    "p": 0.07183,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000681",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2612.0,
                    "cmap_score": -0.188649745070093,
                    "p": 0.04286,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000389",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3475.0,
                    "cmap_score": -0.206082040609766,
                    "p": 0.01855,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000601",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4258.0,
                    "cmap_score": -0.178579174584814,
                    "p": 0.06618,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000580",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8960.0,
                    "cmap_score": -0.195268175590074,
                    "p": 0.03136,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "bergenin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000389",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10959.0,
                    "cmap_score": -0.172603448008758,
                    "p": 0.08331,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12263.0,
                    "cmap_score": -0.198483739396568,
                    "p": 0.02696,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000861",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12337.0,
                    "cmap_score": -0.225339382969787,
                    "p": 0.00657,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000790",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12722.0,
                    "cmap_score": -0.190792701189788,
                    "p": 0.03908,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000950",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13075.0,
                    "cmap_score": -0.219419599823735,
                    "p": 0.00917,
                    "q": 0.9107671875,
                    "subset_comparison_id": "filefb03a55ab8a_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000496",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Chronic_obstructive_pulmonary_disease": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": 0.0956853930680991,
                    "p": 0.46525,
                    "q": 0.978815964125561,
                    "subset_comparison_id": "filefb0d9915e3_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": 0.0928957428562491,
                    "p": 0.47419,
                    "q": 0.978815964125561,
                    "subset_comparison_id": "filefb0d9915e3_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.0965628094610546,
                    "p": 0.46194,
                    "q": 0.978815964125561,
                    "subset_comparison_id": "filefb0d9915e3_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.10716526488249,
                    "p": 0.40859,
                    "q": 0.978815964125561,
                    "subset_comparison_id": "filefb0d9915e3_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 403.0,
                    "cmap_score": -0.120215799203712,
                    "p": 0.32282,
                    "q": 0.978815964125561,
                    "subset_comparison_id": "filefb0d9915e3_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.101930286721033,
                    "p": 0.43752,
                    "q": 0.978815964125561,
                    "subset_comparison_id": "filefb0d9915e3_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.101681117324591,
                    "p": 0.43875,
                    "q": 0.978815964125561,
                    "subset_comparison_id": "filefb0d9915e3_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 284.0,
                    "cmap_score": -0.0923770303596196,
                    "p": 0.47569,
                    "q": 0.978815964125561,
                    "subset_comparison_id": "filefb0d9915e3_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2440.0,
                    "cmap_score": -0.157142372889451,
                    "p": 0.0981,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-001190",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2601.0,
                    "cmap_score": -0.145063475449989,
                    "p": 0.15665,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000757",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3507.0,
                    "cmap_score": -0.122548121079095,
                    "p": 0.30368,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001333",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4307.0,
                    "cmap_score": -0.156412305599897,
                    "p": 0.10127,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001333",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8950.0,
                    "cmap_score": -0.12793149322346,
                    "p": 0.26588,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "bergenin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000555",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11011.0,
                    "cmap_score": -0.136522144222782,
                    "p": 0.20807,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000997",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12191.0,
                    "cmap_score": -0.154096926436999,
                    "p": 0.11114,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "captopril",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000437",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12443.0,
                    "cmap_score": -0.112454199357088,
                    "p": 0.37245,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12684.0,
                    "cmap_score": -0.136580982117207,
                    "p": 0.2077,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000139",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13109.0,
                    "cmap_score": -0.137535211192861,
                    "p": 0.20159,
                    "q": 0.993617219985086,
                    "subset_comparison_id": "filefb03d6bf10e_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Colorectal_cancer": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": 0.125371222311618,
                    "p": 0.34639,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 29.0,
                    "cmap_score": -0.103304147687344,
                    "p": 0.46131,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.120900570695991,
                    "p": 0.37453,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 99.0,
                    "cmap_score": -0.14873639930275,
                    "p": 0.19743,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 403.0,
                    "cmap_score": -0.174378670421516,
                    "p": 0.07927,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.132644753577242,
                    "p": 0.29848,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": 0.096444852207214,
                    "p": 0.48012,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": 0.0979294775039795,
                    "p": 0.47663,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 343.0,
                    "cmap_score": -0.13005342158465,
                    "p": 0.31527,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 142.0,
                    "cmap_score": -0.10463932695487,
                    "p": 0.4564,
                    "q": 0.915408983050847,
                    "subset_comparison_id": "filefb0799eeda2_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2463.0,
                    "cmap_score": -0.149154965321379,
                    "p": 0.19971,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000997",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2628.0,
                    "cmap_score": -0.193095384178686,
                    "p": 0.035,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000521",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3597.0,
                    "cmap_score": -0.178437413816878,
                    "p": 0.06862,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "allantoin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000958",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4316.0,
                    "cmap_score": -0.159313314888923,
                    "p": 0.14365,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000148",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8936.0,
                    "cmap_score": -0.182647706868831,
                    "p": 0.05729,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000348",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11073.0,
                    "cmap_score": -0.173258376632712,
                    "p": 0.08515,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000601",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12242.0,
                    "cmap_score": -0.170280428876554,
                    "p": 0.09586,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000890",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12371.0,
                    "cmap_score": -0.173052041403105,
                    "p": 0.08587,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000957",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12726.0,
                    "cmap_score": -0.152826742219314,
                    "p": 0.17865,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000521",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13127.0,
                    "cmap_score": -0.169119404698337,
                    "p": 0.09966,
                    "q": 0.91652333926372,
                    "subset_comparison_id": "filefb03103650f_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000311",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "CoreFibroidSignature_sirota_lab": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.104948860483701,
                    "p": 0.07241,
                    "q": 0.993406567164179,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 29.0,
                    "cmap_score": 0.074230990945276,
                    "p": 0.35424,
                    "q": 0.999443483146067,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.0876038633989982,
                    "p": 0.20632,
                    "q": 0.999443483146067,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.131547026568349,
                    "p": 0.00767,
                    "q": 0.993406567164179,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 268.0,
                    "cmap_score": 0.070227531753868,
                    "p": 0.39573,
                    "q": 0.999443483146067,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": 0.0865564384632189,
                    "p": 0.21729,
                    "q": 0.999443483146067,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.10731470091639,
                    "p": 0.06118,
                    "q": 0.993406567164179,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 343.0,
                    "cmap_score": -0.0915722743294667,
                    "p": 0.1669,
                    "q": 0.999443483146067,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 142.0,
                    "cmap_score": -0.0820971539628014,
                    "p": 0.26621,
                    "q": 0.999443483146067,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.0903046215169806,
                    "p": 0.17934,
                    "q": 0.999443483146067,
                    "subset_comparison_id": "filefb055dfd4ec_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Crohn's_disease": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.163103146123271,
                    "p": 0.10095,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 29.0,
                    "cmap_score": -0.103757011773627,
                    "p": 0.44521,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.086582495514375,
                    "p": 0.4908,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.116675963200573,
                    "p": 0.37613,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 432.0,
                    "cmap_score": -0.124296410036453,
                    "p": 0.32626,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.0857592692622133,
                    "p": 0.49173,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.131397342418777,
                    "p": 0.27882,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 227.0,
                    "cmap_score": -0.123410831526818,
                    "p": 0.33221,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 95.0,
                    "cmap_score": -0.112448730387087,
                    "p": 0.40107,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": -0.106553873855124,
                    "p": 0.43305,
                    "q": 0.906024937238494,
                    "subset_comparison_id": "filefb056889e8c_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Dermatomyositis": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.12126074584406,
                    "p": 0.40193,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": -0.158456551582572,
                    "p": 0.18229,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.167513441901453,
                    "p": 0.13866,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.160776430925323,
                    "p": 0.17069,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.121249091661965,
                    "p": 0.40201,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 432.0,
                    "cmap_score": -0.162551101890405,
                    "p": 0.16196,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.18094416284739,
                    "p": 0.08763,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.0921581618366219,
                    "p": 0.49407,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 243.0,
                    "cmap_score": -0.206937841847816,
                    "p": 0.0316,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 142.0,
                    "cmap_score": -0.128417682740346,
                    "p": 0.36228,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.129553643753317,
                    "p": 0.35571,
                    "q": 0.812901578947368,
                    "subset_comparison_id": "filefb01284e039_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Duchenne_muscular_dystrophy": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.0958325464151905,
                    "p": 0.46872,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": -0.0959174362239352,
                    "p": 0.46834,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.0706422744757502,
                    "p": 0.50066,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.0979816604264869,
                    "p": 0.4613,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.101720511337787,
                    "p": 0.44624,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 206.0,
                    "cmap_score": -0.128638368765742,
                    "p": 0.27545,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.0968386983303057,
                    "p": 0.46522,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.10314274013659,
                    "p": 0.43972,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.146570042853777,
                    "p": 0.15952,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 243.0,
                    "cmap_score": -0.157728379870212,
                    "p": 0.10491,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 95.0,
                    "cmap_score": -0.158807415007973,
                    "p": 0.10043,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.118939448514785,
                    "p": 0.34484,
                    "q": 0.953562719298246,
                    "subset_comparison_id": "filefb03f1adc9b_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Eczema": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.163707915551036,
                    "p": 0.08298,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": -0.123862002023605,
                    "p": 0.30978,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.134240234506514,
                    "p": 0.23815,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.128114971263497,
                    "p": 0.28034,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 403.0,
                    "cmap_score": -0.118448039794355,
                    "p": 0.34764,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.157558308833704,
                    "p": 0.10708,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 284.0,
                    "cmap_score": -0.085260427365709,
                    "p": 0.4915,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 390.0,
                    "cmap_score": -0.135945696083956,
                    "p": 0.22679,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.143235489044524,
                    "p": 0.18106,
                    "q": 0.931404978540773,
                    "subset_comparison_id": "filefb02023c576_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2431.0,
                    "cmap_score": -0.207293516250112,
                    "p": 0.00864,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2581.0,
                    "cmap_score": -0.196085766355,
                    "p": 0.01677,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3496.0,
                    "cmap_score": -0.195733455827265,
                    "p": 0.01718,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000236",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4281.0,
                    "cmap_score": -0.218872868530672,
                    "p": 0.0041,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8881.0,
                    "cmap_score": -0.210975943240732,
                    "p": 0.00682,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000628",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11059.0,
                    "cmap_score": -0.20164266422428,
                    "p": 0.01215,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12202.0,
                    "cmap_score": -0.192492423731607,
                    "p": 0.02032,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000940",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12443.0,
                    "cmap_score": -0.181249016677155,
                    "p": 0.03705,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12631.0,
                    "cmap_score": -0.191086459363481,
                    "p": 0.02211,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000628",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13131.0,
                    "cmap_score": -0.215593814618358,
                    "p": 0.0051,
                    "q": 0.934177190932132,
                    "subset_comparison_id": "filefb0c78d676_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000628",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Endometrial_cancer": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": -0.132239925087375,
                    "p": 0.33618,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": -0.13342456130035,
                    "p": 0.32852,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.128123160732724,
                    "p": 0.36046,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.131570570582305,
                    "p": 0.33988,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 99.0,
                    "cmap_score": 0.148987433452988,
                    "p": 0.23101,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 58.0,
                    "cmap_score": -0.122926615263168,
                    "p": 0.39089,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.171100353306788,
                    "p": 0.11548,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 343.0,
                    "cmap_score": 0.128586402554631,
                    "p": 0.35782,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 142.0,
                    "cmap_score": 0.104723664793913,
                    "p": 0.47043,
                    "q": 0.855902677165354,
                    "subset_comparison_id": "filefb05147e35f_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2411.0,
                    "cmap_score": -0.219737840228687,
                    "p": 0.01333,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2575.0,
                    "cmap_score": -0.278702397297605,
                    "p": 0.00034,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000601",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3535.0,
                    "cmap_score": -0.202587512541299,
                    "p": 0.03115,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4336.0,
                    "cmap_score": -0.246311085271512,
                    "p": 0.00286,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000139",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8903.0,
                    "cmap_score": -0.185967934950011,
                    "p": 0.06435,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000222",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10970.0,
                    "cmap_score": -0.225329276901311,
                    "p": 0.00975,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000750",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12168.0,
                    "cmap_score": -0.210199006619726,
                    "p": 0.0218,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "captopril",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000396",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12366.0,
                    "cmap_score": -0.210846485374819,
                    "p": 0.02123,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001021",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12700.0,
                    "cmap_score": -0.204843540119249,
                    "p": 0.02806,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000555",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13099.0,
                    "cmap_score": -0.197313972930336,
                    "p": 0.0394,
                    "q": 0.962190267495662,
                    "subset_comparison_id": "filefb046a09ba9_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000757",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Endothelia_sirota_lab": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2503.0,
                    "cmap_score": -0.0519333316239122,
                    "p": 0.07592,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000681",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2595.0,
                    "cmap_score": -0.0569808175929946,
                    "p": 0.036,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3522.0,
                    "cmap_score": -0.0556502315509846,
                    "p": 0.04421,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000750",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4297.0,
                    "cmap_score": -0.0656049751095095,
                    "p": 0.00821,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000958",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8929.0,
                    "cmap_score": -0.0677024697352017,
                    "p": 0.0054,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11088.0,
                    "cmap_score": -0.0577402413417817,
                    "p": 0.03234,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001190",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12238.0,
                    "cmap_score": -0.0706722497607973,
                    "p": 0.00289,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001190",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12446.0,
                    "cmap_score": -0.0557384649149635,
                    "p": 0.04368,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000842",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12663.0,
                    "cmap_score": -0.0653540674616095,
                    "p": 0.00854,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000861",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13079.0,
                    "cmap_score": -0.0579959793885474,
                    "p": 0.03118,
                    "q": 0.971022335475972,
                    "subset_comparison_id": "filefb019071c98_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Epithelial_proliferation": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": 0.176806430199393,
                    "p": 0.04413,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": -0.113130268940224,
                    "p": 0.37724,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.107338479976107,
                    "p": 0.4125,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": -0.159148417660323,
                    "p": 0.09661,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 99.0,
                    "cmap_score": -0.134724986063958,
                    "p": 0.22771,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 362.0,
                    "cmap_score": -0.133994721265149,
                    "p": 0.23225,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.148116245161385,
                    "p": 0.14761,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": 0.0678741709791342,
                    "p": 0.50112,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 284.0,
                    "cmap_score": -0.101510851074996,
                    "p": 0.44324,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": -0.085394206716132,
                    "p": 0.49125,
                    "q": 0.89881041322314,
                    "subset_comparison_id": "filefb021e64bfe_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            }
        }
    },
    "Glioblastoma": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": -0.138272687081678,
                    "p": 0.29494,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": -0.180713892362777,
                    "p": 0.07929,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.15608938473226,
                    "p": 0.1858,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.135224990432626,
                    "p": 0.31459,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11.0,
                    "cmap_score": -0.0904081453666443,
                    "p": 0.49729,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 432.0,
                    "cmap_score": -0.15477517118345,
                    "p": 0.19343,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.11074194709728,
                    "p": 0.44932,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": 0.111352720849232,
                    "p": 0.44667,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.115495661757596,
                    "p": 0.42779,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 243.0,
                    "cmap_score": -0.166183208771219,
                    "p": 0.13561,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 390.0,
                    "cmap_score": -0.150294078170795,
                    "p": 0.21936,
                    "q": 0.842378918918919,
                    "subset_comparison_id": "filefb01ce9c41_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2543.0,
                    "cmap_score": -0.236937087863687,
                    "p": 0.00527,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000437",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2601.0,
                    "cmap_score": -0.216535666195654,
                    "p": 0.01567,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000757",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3504.0,
                    "cmap_score": -0.22153231337461,
                    "p": 0.01241,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000940",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4320.0,
                    "cmap_score": -0.188042192960694,
                    "p": 0.05933,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000396",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8862.0,
                    "cmap_score": -0.186467805277502,
                    "p": 0.06331,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000954",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10979.0,
                    "cmap_score": -0.176547825789935,
                    "p": 0.09388,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12215.0,
                    "cmap_score": -0.196350762160044,
                    "p": 0.04132,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000552",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12412.0,
                    "cmap_score": -0.185006170808704,
                    "p": 0.06704,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000954",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12643.0,
                    "cmap_score": -0.237471022367721,
                    "p": 0.00513,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13088.0,
                    "cmap_score": -0.221248379769455,
                    "p": 0.01259,
                    "q": 0.877273840020912,
                    "subset_comparison_id": "filefb023747054_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-001190",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Hepatitis_C": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2509.0,
                    "cmap_score": -0.217790055333728,
                    "p": 0.00977,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2596.0,
                    "cmap_score": -0.194475870058168,
                    "p": 0.03245,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000236",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3591.0,
                    "cmap_score": -0.207145629991127,
                    "p": 0.01713,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "allantoin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000932",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4281.0,
                    "cmap_score": -0.193494974982747,
                    "p": 0.03415,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8881.0,
                    "cmap_score": -0.185827125234152,
                    "p": 0.04935,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000628",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11007.0,
                    "cmap_score": -0.185886048259884,
                    "p": 0.04915,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12163.0,
                    "cmap_score": -0.212448625283447,
                    "p": 0.01278,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "captopril",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000861",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12406.0,
                    "cmap_score": -0.209100488021295,
                    "p": 0.01542,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000580",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12710.0,
                    "cmap_score": -0.204123918589175,
                    "p": 0.01994,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000389",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13153.0,
                    "cmap_score": -0.210370452528838,
                    "p": 0.01447,
                    "q": 0.825654720167653,
                    "subset_comparison_id": "filefb06cf2ac1d_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000222",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "HIV_AIDS": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2485.0,
                    "cmap_score": -0.20751670537618,
                    "p": 0.01645,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2681.0,
                    "cmap_score": -0.185067963752665,
                    "p": 0.04819,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3462.0,
                    "cmap_score": -0.197632691136156,
                    "p": 0.02695,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000389",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4340.0,
                    "cmap_score": -0.151854725098995,
                    "p": 0.17191,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001190",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8885.0,
                    "cmap_score": -0.177764715961011,
                    "p": 0.06592,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11085.0,
                    "cmap_score": -0.182070752741395,
                    "p": 0.05501,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12155.0,
                    "cmap_score": -0.161669728525739,
                    "p": 0.12365,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "captopril",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-001333",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12435.0,
                    "cmap_score": -0.202925106609808,
                    "p": 0.02069,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12696.0,
                    "cmap_score": -0.210998181922022,
                    "p": 0.01381,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000842",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13179.0,
                    "cmap_score": -0.173981019646665,
                    "p": 0.07748,
                    "q": 0.895422216092573,
                    "subset_comparison_id": "filefb04a0546b3_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Hypercholesterolemia": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": 0.117694959319488,
                    "p": 0.42339,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": -0.137315605115304,
                    "p": 0.30902,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.144091539314509,
                    "p": 0.26602,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.146201728473825,
                    "p": 0.25331,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.113946925713176,
                    "p": 0.43979,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 58.0,
                    "cmap_score": -0.159226755607546,
                    "p": 0.17658,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.110011443063503,
                    "p": 0.45542,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.215019196280481,
                    "p": 0.01863,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 258.0,
                    "cmap_score": -0.15513458084515,
                    "p": 0.19936,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 95.0,
                    "cmap_score": -0.158811355169814,
                    "p": 0.17887,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.193379609075471,
                    "p": 0.05166,
                    "q": 0.884760162601626,
                    "subset_comparison_id": "filefb02bdc5e41_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Hypoxia": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": -0.120590162771183,
                    "p": 0.34013,
                    "q": 0.992124,
                    "subset_comparison_id": "filefb078a56727_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": -0.119714219172369,
                    "p": 0.34603,
                    "q": 0.992124,
                    "subset_comparison_id": "filefb078a56727_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11.0,
                    "cmap_score": -0.126637099245465,
                    "p": 0.29822,
                    "q": 0.992124,
                    "subset_comparison_id": "filefb078a56727_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 58.0,
                    "cmap_score": 0.13786864966123,
                    "p": 0.2216,
                    "q": 0.992124,
                    "subset_comparison_id": "filefb078a56727_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.138509126298125,
                    "p": 0.21734,
                    "q": 0.992124,
                    "subset_comparison_id": "filefb078a56727_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 258.0,
                    "cmap_score": -0.136523401534545,
                    "p": 0.23045,
                    "q": 0.992124,
                    "subset_comparison_id": "filefb078a56727_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 142.0,
                    "cmap_score": -0.168456196760075,
                    "p": 0.07351,
                    "q": 0.992124,
                    "subset_comparison_id": "filefb078a56727_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": -0.0821093682903687,
                    "p": 0.49812,
                    "q": 0.992124,
                    "subset_comparison_id": "filefb078a56727_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Leukemia": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 327.0,
                    "cmap_score": 0.162093091077369,
                    "p": 0.1881,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 37.0,
                    "cmap_score": -0.181905835430197,
                    "p": 0.09811,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": -0.169048232558495,
                    "p": 0.15277,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11.0,
                    "cmap_score": -0.168696898836693,
                    "p": 0.15443,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 58.0,
                    "cmap_score": -0.216910630210025,
                    "p": 0.02367,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.112613098626121,
                    "p": 0.45887,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": -0.154700594410052,
                    "p": 0.22942,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 243.0,
                    "cmap_score": -0.166682584535833,
                    "p": 0.16443,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": -0.101448139156337,
                    "p": 0.48791,
                    "q": 0.982619009009009,
                    "subset_comparison_id": "filefb07e1587f_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2424.0,
                    "cmap_score": -0.2170044352182,
                    "p": 0.02298,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000950",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2604.0,
                    "cmap_score": -0.172967569420606,
                    "p": 0.1328,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000940",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3583.0,
                    "cmap_score": -0.291825586379424,
                    "p": 0.00032,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "allantoin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000628",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4311.0,
                    "cmap_score": -0.211527688768128,
                    "p": 0.02935,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8866.0,
                    "cmap_score": -0.195201031273877,
                    "p": 0.05978,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-001021",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11065.0,
                    "cmap_score": -0.221964483534868,
                    "p": 0.01823,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000552",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12293.0,
                    "cmap_score": -0.247568753322002,
                    "p": 0.00459,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12447.0,
                    "cmap_score": -0.203634878225571,
                    "p": 0.04205,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": NaN,
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12651.0,
                    "cmap_score": -0.245025533273537,
                    "p": 0.0053,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000681",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13061.0,
                    "cmap_score": -0.227685203897077,
                    "p": 0.01366,
                    "q": 0.917732802758621,
                    "subset_comparison_id": "filefb05b78fde3_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000997",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Lupus": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.143124688472864,
                    "p": 0.26322,
                    "q": 0.95327421875,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 29.0,
                    "cmap_score": 0.17363206281928,
                    "p": 0.10363,
                    "q": 0.95327421875,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.0997242208362605,
                    "p": 0.4835,
                    "q": 0.970149266055046,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.165176129002587,
                    "p": 0.13878,
                    "q": 0.95327421875,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 403.0,
                    "cmap_score": -0.132635595046037,
                    "p": 0.3307,
                    "q": 0.967845380116959,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.171534551055479,
                    "p": 0.11176,
                    "q": 0.95327421875,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 243.0,
                    "cmap_score": -0.171192137751768,
                    "p": 0.11307,
                    "q": 0.95327421875,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": -0.100618512672638,
                    "p": 0.48137,
                    "q": 0.970149266055046,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.184111029232734,
                    "p": 0.06848,
                    "q": 0.95327421875,
                    "subset_comparison_id": "filefb061d009c_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Lymphoma": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 327.0,
                    "cmap_score": -0.164834360081075,
                    "p": 0.13373,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": -0.137363383909981,
                    "p": 0.29139,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.156880651898482,
                    "p": 0.17297,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.149725949316248,
                    "p": 0.21363,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 432.0,
                    "cmap_score": -0.165943453467574,
                    "p": 0.1287,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": -0.095276084535147,
                    "p": 0.48828,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": 0.110595611910874,
                    "p": 0.44555,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 258.0,
                    "cmap_score": 0.110357234434228,
                    "p": 0.44652,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 95.0,
                    "cmap_score": -0.15816781415674,
                    "p": 0.16672,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.154250533581007,
                    "p": 0.18681,
                    "q": 0.92488170212766,
                    "subset_comparison_id": "filefb016a6c63d_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2500.0,
                    "cmap_score": -0.241678861983665,
                    "p": 0.00294,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000558",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2627.0,
                    "cmap_score": -0.234309441841,
                    "p": 0.0047,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000496",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3533.0,
                    "cmap_score": -0.223250021991555,
                    "p": 0.0093,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000628",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4306.0,
                    "cmap_score": -0.21896283493805,
                    "p": 0.01202,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000927",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8906.0,
                    "cmap_score": -0.231628054826946,
                    "p": 0.0056,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000580",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10958.0,
                    "cmap_score": -0.239207894168639,
                    "p": 0.00341,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000120",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12224.0,
                    "cmap_score": -0.236632633068902,
                    "p": 0.00405,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000916",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12372.0,
                    "cmap_score": -0.231177811053889,
                    "p": 0.00574,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000950",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12691.0,
                    "cmap_score": -0.232441659069584,
                    "p": 0.00534,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000437",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13162.0,
                    "cmap_score": -0.224482298797262,
                    "p": 0.00863,
                    "q": 0.706789192982456,
                    "subset_comparison_id": "filefb01f20da69_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000954",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Melanoma": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2468.0,
                    "cmap_score": -0.25468593687475,
                    "p": 0.00466,
                    "q": 0.872211155172414,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001021",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2652.0,
                    "cmap_score": -0.224800545218087,
                    "p": 0.02169,
                    "q": 0.872211155172414,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000555",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3518.0,
                    "cmap_score": -0.241491284013605,
                    "p": 0.0097,
                    "q": 0.872211155172414,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001021",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4247.0,
                    "cmap_score": -0.246458583433373,
                    "p": 0.00755,
                    "q": 0.872211155172414,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000958",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8877.0,
                    "cmap_score": -0.277951493097239,
                    "p": 0.00133,
                    "q": 0.855063333333333,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000311",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10968.0,
                    "cmap_score": -0.262902973689476,
                    "p": 0.00287,
                    "q": 0.872211155172414,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000396",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12182.0,
                    "cmap_score": -0.287117972188876,
                    "p": 0.0008,
                    "q": 0.635341176470588,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "captopril",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000853",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12358.0,
                    "cmap_score": -0.26281919017607,
                    "p": 0.00288,
                    "q": 0.872211155172414,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000120",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12686.0,
                    "cmap_score": -0.231521358543417,
                    "p": 0.01585,
                    "q": 0.872211155172414,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000348",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13144.0,
                    "cmap_score": -0.229412077330932,
                    "p": 0.01759,
                    "q": 0.872211155172414,
                    "subset_comparison_id": "filefb06a24ab9b_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000236",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Meningococcal_infection": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2463.0,
                    "cmap_score": -0.186195984075448,
                    "p": 0.17055,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000997",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2622.0,
                    "cmap_score": -0.165610505565863,
                    "p": 0.26631,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000750",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3595.0,
                    "cmap_score": -0.191579700061843,
                    "p": 0.14904,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "allantoin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4261.0,
                    "cmap_score": -0.205377435064935,
                    "p": 0.10324,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8967.0,
                    "cmap_score": -0.202081400742115,
                    "p": 0.11299,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "bergenin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000178",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11082.0,
                    "cmap_score": -0.182167980828695,
                    "p": 0.18794,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000853",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12180.0,
                    "cmap_score": -0.221153660327767,
                    "p": 0.06498,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "captopril",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000463",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12389.0,
                    "cmap_score": -0.302550054112554,
                    "p": 0.00291,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000932",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12674.0,
                    "cmap_score": -0.192987592764378,
                    "p": 0.14345,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000916",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13179.0,
                    "cmap_score": -0.180249884044527,
                    "p": 0.19612,
                    "q": 0.96157743608056,
                    "subset_comparison_id": "filefb06ceee68d_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Obesity": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.17885814007602,
                    "p": 0.04329,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 29.0,
                    "cmap_score": 0.114431336444549,
                    "p": 0.37901,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.0879694639984684,
                    "p": 0.48954,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11.0,
                    "cmap_score": -0.141907951509519,
                    "p": 0.19328,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 58.0,
                    "cmap_score": -0.107368524147545,
                    "p": 0.42036,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.106148870159221,
                    "p": 0.42724,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 258.0,
                    "cmap_score": -0.110915734118695,
                    "p": 0.40047,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 95.0,
                    "cmap_score": -0.118942731183359,
                    "p": 0.34813,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.106745149631533,
                    "p": 0.42389,
                    "q": 0.895522386831276,
                    "subset_comparison_id": "filefb0672618b5_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2442.0,
                    "cmap_score": -0.186982937986033,
                    "p": 0.02861,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000493",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2631.0,
                    "cmap_score": -0.170989555075609,
                    "p": 0.06183,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3506.0,
                    "cmap_score": -0.195892381108885,
                    "p": 0.01744,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000927",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4209.0,
                    "cmap_score": -0.182740258040844,
                    "p": 0.03539,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8883.0,
                    "cmap_score": -0.175709464511776,
                    "p": 0.04966,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11021.0,
                    "cmap_score": -0.192006672300822,
                    "p": 0.02185,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000957",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12281.0,
                    "cmap_score": -0.205201236297177,
                    "p": 0.0102,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000628",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12435.0,
                    "cmap_score": -0.187663568750609,
                    "p": 0.02755,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12600.0,
                    "cmap_score": -0.180374869145,
                    "p": 0.03966,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000555",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13128.0,
                    "cmap_score": -0.147767085489615,
                    "p": 0.15725,
                    "q": 0.911460773654662,
                    "subset_comparison_id": "filefb0762047fa_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000900",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Oligodendroglioma": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 327.0,
                    "cmap_score": -0.216544338532176,
                    "p": 0.06035,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 37.0,
                    "cmap_score": -0.124124955112437,
                    "p": 0.45584,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.170822560936077,
                    "p": 0.2272,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.169151886826416,
                    "p": 0.23606,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 206.0,
                    "cmap_score": -0.171919599657173,
                    "p": 0.22135,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.130326008721059,
                    "p": 0.43333,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": 0.187707300768352,
                    "p": 0.14702,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 227.0,
                    "cmap_score": -0.182272600093327,
                    "p": 0.17081,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": 0.161968798925109,
                    "p": 0.27484,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.141841959859994,
                    "p": 0.38229,
                    "q": 0.967588533333333,
                    "subset_comparison_id": "filefb04155aaac_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2511.0,
                    "cmap_score": -0.219814268909318,
                    "p": 0.05505,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2660.0,
                    "cmap_score": -0.174551756009421,
                    "p": 0.20842,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000120",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3519.0,
                    "cmap_score": -0.261973155490266,
                    "p": 0.01022,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000178",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4289.0,
                    "cmap_score": -0.18953433895488,
                    "p": 0.14291,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000790",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8929.0,
                    "cmap_score": -0.237920853648477,
                    "p": 0.02724,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11024.0,
                    "cmap_score": -0.229115577151913,
                    "p": 0.0387,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000916",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12285.0,
                    "cmap_score": -0.228738370348139,
                    "p": 0.03919,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12375.0,
                    "cmap_score": -0.244702897606411,
                    "p": 0.02072,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000496",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12743.0,
                    "cmap_score": -0.216154252271084,
                    "p": 0.06254,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13183.0,
                    "cmap_score": -0.231303129804553,
                    "p": 0.03546,
                    "q": 0.995346952054795,
                    "subset_comparison_id": "filefb05f3823b6_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Ovarian_cancer": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": 0.130146891541295,
                    "p": 0.36277,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 178.0,
                    "cmap_score": 0.121861237374529,
                    "p": 0.40995,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.11630476879836,
                    "p": 0.43638,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": -0.164529735445517,
                    "p": 0.1607,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11.0,
                    "cmap_score": 0.167336383999595,
                    "p": 0.14729,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 362.0,
                    "cmap_score": -0.124030766096581,
                    "p": 0.39867,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.117084822127948,
                    "p": 0.43315,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.108223700734439,
                    "p": 0.46674,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.100107407449917,
                    "p": 0.48595,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 284.0,
                    "cmap_score": -0.129346857604753,
                    "p": 0.36725,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": -0.146923870039086,
                    "p": 0.25889,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": -0.106028303596874,
                    "p": 0.473,
                    "q": 0.928518888888889,
                    "subset_comparison_id": "filefb05eb0b290_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2511.0,
                    "cmap_score": -0.179105174994669,
                    "p": 0.09873,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2586.0,
                    "cmap_score": -0.192652150913449,
                    "p": 0.05782,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000139",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3458.0,
                    "cmap_score": -0.169970278935639,
                    "p": 0.13541,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000580",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4280.0,
                    "cmap_score": -0.177193199385416,
                    "p": 0.10573,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000900",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8982.0,
                    "cmap_score": -0.208422967265774,
                    "p": 0.02913,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "bergenin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000853",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10954.0,
                    "cmap_score": -0.1522422132402,
                    "p": 0.22893,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000927",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12242.0,
                    "cmap_score": -0.16364270366893,
                    "p": 0.16535,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000890",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12348.0,
                    "cmap_score": -0.148579823423303,
                    "p": 0.25096,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000558",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12665.0,
                    "cmap_score": -0.152088766181397,
                    "p": 0.22987,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000552",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13186.0,
                    "cmap_score": -0.144940325725841,
                    "p": 0.27343,
                    "q": 0.907074380939452,
                    "subset_comparison_id": "filefb0229b3c81_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000348",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Pancreatic_cancer": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": -0.115065455186266,
                    "p": 0.39734,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 178.0,
                    "cmap_score": -0.130294903774,
                    "p": 0.29805,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.151609219340655,
                    "p": 0.16412,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.163165789453386,
                    "p": 0.10961,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 432.0,
                    "cmap_score": -0.130934087269535,
                    "p": 0.29359,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.140384503415827,
                    "p": 0.23123,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.135826857935782,
                    "p": 0.26039,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.152471667487535,
                    "p": 0.1598,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 258.0,
                    "cmap_score": -0.189204111191486,
                    "p": 0.0357,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 427.0,
                    "cmap_score": -0.128967764676897,
                    "p": 0.30778,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.094344403623907,
                    "p": 0.48206,
                    "q": 0.918267088607595,
                    "subset_comparison_id": "filefb07da14ae6_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Parkinson's_disease": {
        "CMAP": {
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 37.0,
                    "cmap_score": 0.0971893834671619,
                    "p": 0.46222,
                    "q": 0.9734,
                    "subset_comparison_id": "filefb05c9a0b65_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.14367612581894,
                    "p": 0.17079,
                    "q": 0.9734,
                    "subset_comparison_id": "filefb05c9a0b65_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": -0.123339983819861,
                    "p": 0.306,
                    "q": 0.9734,
                    "subset_comparison_id": "filefb05c9a0b65_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 99.0,
                    "cmap_score": -0.128711147845781,
                    "p": 0.2684,
                    "q": 0.9734,
                    "subset_comparison_id": "filefb05c9a0b65_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 362.0,
                    "cmap_score": -0.133176287036224,
                    "p": 0.23671,
                    "q": 0.9734,
                    "subset_comparison_id": "filefb05c9a0b65_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 243.0,
                    "cmap_score": -0.103009811908943,
                    "p": 0.43648,
                    "q": 0.9734,
                    "subset_comparison_id": "filefb05c9a0b65_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 390.0,
                    "cmap_score": -0.126583027625728,
                    "p": 0.28293,
                    "q": 0.9734,
                    "subset_comparison_id": "filefb05c9a0b65_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": -0.136655041785863,
                    "p": 0.21423,
                    "q": 0.9734,
                    "subset_comparison_id": "filefb05c9a0b65_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2526.0,
                    "cmap_score": -0.151556874877007,
                    "p": 0.12787,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000916",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2665.0,
                    "cmap_score": -0.141010610320419,
                    "p": 0.18548,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000861",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3542.0,
                    "cmap_score": -0.222740464059986,
                    "p": 0.00272,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000493",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4216.0,
                    "cmap_score": -0.17836678985264,
                    "p": 0.0391,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000148",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8915.0,
                    "cmap_score": -0.150929872622617,
                    "p": 0.13117,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000552",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10964.0,
                    "cmap_score": -0.181199735637307,
                    "p": 0.03362,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000148",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12234.0,
                    "cmap_score": -0.189482955334715,
                    "p": 0.02164,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000139",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12392.0,
                    "cmap_score": -0.171743795362728,
                    "p": 0.05402,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000890",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12726.0,
                    "cmap_score": -0.171325799888872,
                    "p": 0.05509,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000521",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13123.0,
                    "cmap_score": -0.178849419979279,
                    "p": 0.03814,
                    "q": 0.938297561113466,
                    "subset_comparison_id": "filefb05624362_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000601",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Prostate_cancer": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2436.0,
                    "cmap_score": -0.107775509162636,
                    "p": 0.40979,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000139",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2608.0,
                    "cmap_score": -0.160702217966182,
                    "p": 0.09235,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000580",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3509.0,
                    "cmap_score": -0.150283582316883,
                    "p": 0.13849,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4237.0,
                    "cmap_score": -0.17496595775481,
                    "p": 0.04861,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8940.0,
                    "cmap_score": -0.135222290653861,
                    "p": 0.22662,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000493",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11066.0,
                    "cmap_score": -0.156457693495341,
                    "p": 0.10941,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001021",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12232.0,
                    "cmap_score": -0.160982783346039,
                    "p": 0.09129,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000853",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12346.0,
                    "cmap_score": -0.145301366298203,
                    "p": 0.16575,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000842",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12721.0,
                    "cmap_score": -0.132885729881359,
                    "p": 0.24185,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000957",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13061.0,
                    "cmap_score": -0.17096876353879,
                    "p": 0.0591,
                    "q": 0.973072365810969,
                    "subset_comparison_id": "filefb05809ca12_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000997",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Psoriasis": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.152838555108815,
                    "p": 0.18311,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": -0.111325340279843,
                    "p": 0.43469,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.129947281682967,
                    "p": 0.32762,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.162845890867339,
                    "p": 0.13175,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 432.0,
                    "cmap_score": -0.0975945228170011,
                    "p": 0.48101,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-08,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.119068060637216,
                    "p": 0.39389,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.160083970409024,
                    "p": 0.14472,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.114257438320624,
                    "p": 0.42042,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 343.0,
                    "cmap_score": 0.147590998298034,
                    "p": 0.21453,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "resveratrol",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 142.0,
                    "cmap_score": -0.100653170586419,
                    "p": 0.47394,
                    "q": 0.903985833333333,
                    "subset_comparison_id": "filefb06ab190e5_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2522.0,
                    "cmap_score": -0.209374898803452,
                    "p": 0.01642,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000750",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2650.0,
                    "cmap_score": -0.153288754085449,
                    "p": 0.17945,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000558",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3465.0,
                    "cmap_score": -0.191371337190946,
                    "p": 0.04084,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000861",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4254.0,
                    "cmap_score": -0.184701029978465,
                    "p": 0.05485,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000940",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8896.0,
                    "cmap_score": -0.183897285431514,
                    "p": 0.05657,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000842",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11007.0,
                    "cmap_score": -0.181016346206113,
                    "p": 0.06397,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12158.0,
                    "cmap_score": -0.200240546001638,
                    "p": 0.02644,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "captopril",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000120",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12357.0,
                    "cmap_score": -0.216742233381792,
                    "p": 0.01069,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12712.0,
                    "cmap_score": -0.187626983596907,
                    "p": 0.04858,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000954",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13146.0,
                    "cmap_score": -0.190068503918909,
                    "p": 0.04332,
                    "q": 0.94526093480413,
                    "subset_comparison_id": "filefb02f9fe11c_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000842",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Pulmonary_fibrosis": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2518.0,
                    "cmap_score": -0.20647953438132,
                    "p": 0.01293,
                    "q": 0.915973017241379,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001021",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2568.0,
                    "cmap_score": -0.208557122173194,
                    "p": 0.01142,
                    "q": 0.915973017241379,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-001021",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3532.0,
                    "cmap_score": -0.225684150349329,
                    "p": 0.00384,
                    "q": 0.915973017241379,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000463",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4249.0,
                    "cmap_score": -0.24046800307961,
                    "p": 0.00146,
                    "q": 0.89444125,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": NaN,
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8985.0,
                    "cmap_score": -0.234083413770914,
                    "p": 0.00207,
                    "q": 0.89444125,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "bergenin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11078.0,
                    "cmap_score": -0.229545154210333,
                    "p": 0.00284,
                    "q": 0.912924761904762,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000900",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12286.0,
                    "cmap_score": -0.230884439924618,
                    "p": 0.00259,
                    "q": 0.89444125,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000348",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12365.0,
                    "cmap_score": -0.20513507767972,
                    "p": 0.01399,
                    "q": 0.915973017241379,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000552",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12724.0,
                    "cmap_score": -0.214033772292701,
                    "p": 0.00827,
                    "q": 0.915973017241379,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000916",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13185.0,
                    "cmap_score": -0.215508796423975,
                    "p": 0.00753,
                    "q": 0.915973017241379,
                    "subset_comparison_id": "filefb022ef4ba_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000943",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Rheumatoid_arthritis": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": 0.13461057449243,
                    "p": 0.38285,
                    "q": 0.902652886597938,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": -0.161324941634841,
                    "p": 0.22817,
                    "q": 0.765911363636364,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": 0.238403784667224,
                    "p": 0.01317,
                    "q": 0.564729268292683,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 99.0,
                    "cmap_score": -0.185668429875679,
                    "p": 0.11342,
                    "q": 0.722248333333333,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "ssMCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 93.0,
                    "cmap_score": -0.21494904339959,
                    "p": 0.03842,
                    "q": 0.564729268292683,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": 0.107391753111525,
                    "p": 0.48359,
                    "q": 0.980738598130841,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 258.0,
                    "cmap_score": -0.219874544667728,
                    "p": 0.03121,
                    "q": 0.564729268292683,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 142.0,
                    "cmap_score": -0.174414002596497,
                    "p": 0.16003,
                    "q": 0.72748298245614,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": 0.13107827443599,
                    "p": 0.40119,
                    "q": 0.902652886597938,
                    "subset_comparison_id": "filefb058c4e074_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2446.0,
                    "cmap_score": -0.269255448890082,
                    "p": 0.00293,
                    "q": 0.542882315789474,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000236",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2570.0,
                    "cmap_score": -0.272091780791264,
                    "p": 0.00244,
                    "q": 0.542882315789474,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000396",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3512.0,
                    "cmap_score": -0.247946596401719,
                    "p": 0.00871,
                    "q": 0.554851223628692,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000389",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4202.0,
                    "cmap_score": -0.234879050304332,
                    "p": 0.01616,
                    "q": 0.602723214285714,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000555",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8979.0,
                    "cmap_score": -0.260027300393842,
                    "p": 0.00464,
                    "q": 0.552464233128834,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "bergenin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10979.0,
                    "cmap_score": -0.232889701933405,
                    "p": 0.01774,
                    "q": 0.604062599206349,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12262.0,
                    "cmap_score": -0.250802508503401,
                    "p": 0.00746,
                    "q": 0.554851223628692,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000954",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12423.0,
                    "cmap_score": -0.256024268259936,
                    "p": 0.0057,
                    "q": 0.552464233128834,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000601",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12612.0,
                    "cmap_score": -0.298047294575725,
                    "p": 0.0005,
                    "q": 0.54004,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000954",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13051.0,
                    "cmap_score": -0.262613005728607,
                    "p": 0.00395,
                    "q": 0.552464233128834,
                    "subset_comparison_id": "filefb0656c0d33_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000681",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Schizophrenia": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2512.0,
                    "cmap_score": -0.154035471889742,
                    "p": 0.11669,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000389",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2593.0,
                    "cmap_score": -0.0909613936979605,
                    "p": 0.4684,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000437",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3494.0,
                    "cmap_score": -0.125319543766863,
                    "p": 0.28759,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000890",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4345.0,
                    "cmap_score": -0.138329007016479,
                    "p": 0.2014,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8880.0,
                    "cmap_score": -0.12530976371829,
                    "p": 0.28767,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000463",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11026.0,
                    "cmap_score": -0.0962624198622288,
                    "p": 0.45365,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000521",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12250.0,
                    "cmap_score": -0.162836929335498,
                    "p": 0.0811,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000555",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12379.0,
                    "cmap_score": -0.155093356026599,
                    "p": 0.11177,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12706.0,
                    "cmap_score": -0.12228859478983,
                    "p": 0.30885,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000580",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13129.0,
                    "cmap_score": -0.133486470595258,
                    "p": 0.23164,
                    "q": 0.759633081876725,
                    "subset_comparison_id": "filefb03baf3c03_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000875",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Stroke": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": -0.103239993435101,
                    "p": 0.46791,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": -0.0787337620219448,
                    "p": 0.50098,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11.0,
                    "cmap_score": -0.187249282402357,
                    "p": 0.04977,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 403.0,
                    "cmap_score": -0.104867377983143,
                    "p": 0.46246,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": -0.117990233648054,
                    "p": 0.40415,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": -0.143960762359846,
                    "p": 0.23952,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.0966145154017903,
                    "p": 0.48484,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 258.0,
                    "cmap_score": -0.195569936565087,
                    "p": 0.03424,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 390.0,
                    "cmap_score": -0.138056571804042,
                    "p": 0.27734,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": -0.132802487994851,
                    "p": 0.31198,
                    "q": 0.919164388185654,
                    "subset_comparison_id": "filefb06d8d0791_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2541.0,
                    "cmap_score": -0.18269384405721,
                    "p": 0.06342,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000932",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2551.0,
                    "cmap_score": -0.177856630841101,
                    "p": 0.07791,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000757",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3460.0,
                    "cmap_score": -0.179158599783004,
                    "p": 0.07383,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000120",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4246.0,
                    "cmap_score": -0.229695166513657,
                    "p": 0.00609,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000236",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8857.0,
                    "cmap_score": -0.231997968957277,
                    "p": 0.00528,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000138",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10974.0,
                    "cmap_score": -0.234275548090523,
                    "p": 0.00459,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000916",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12295.0,
                    "cmap_score": -0.196581661479702,
                    "p": 0.03393,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "captopril",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000958",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12303.0,
                    "cmap_score": -0.215780444226765,
                    "p": 0.013,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000222",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12739.0,
                    "cmap_score": -0.183704766883077,
                    "p": 0.06076,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "celecoxib",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000932",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13093.0,
                    "cmap_score": -0.213296823249317,
                    "p": 0.01474,
                    "q": 0.886429112230025,
                    "subset_comparison_id": "filefb045ebf8c7_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Tuberculosis": {
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2400.0,
                    "cmap_score": -0.143783872639173,
                    "p": 0.23853,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000558",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2554.0,
                    "cmap_score": -0.125729472669628,
                    "p": 0.3524,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000940",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3507.0,
                    "cmap_score": -0.133171223358116,
                    "p": 0.30523,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001333",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4311.0,
                    "cmap_score": -0.1440594419454,
                    "p": 0.23696,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "altretamine",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-001039",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8992.0,
                    "cmap_score": -0.135108225803967,
                    "p": 0.29304,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "bergenin",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000890",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 10955.0,
                    "cmap_score": -0.159667148272618,
                    "p": 0.14899,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "budesonide",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-001333",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12211.0,
                    "cmap_score": -0.130786835078649,
                    "p": 0.3206,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000997",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12373.0,
                    "cmap_score": -0.160142779821254,
                    "p": 0.14675,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000601",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12652.0,
                    "cmap_score": -0.136570059593922,
                    "p": 0.28336,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000940",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13053.0,
                    "cmap_score": -0.124570537373293,
                    "p": 0.35958,
                    "q": 0.77515042939043,
                    "subset_comparison_id": "filefb0390ecf26_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000222",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Type_1_diabetes": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 338.0,
                    "cmap_score": -0.144892373925127,
                    "p": 0.30435,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 178.0,
                    "cmap_score": -0.167325150966648,
                    "p": 0.17639,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": 0.128137861627323,
                    "p": 0.39802,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 268.0,
                    "cmap_score": -0.180779892118539,
                    "p": 0.1172,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.135222793060161,
                    "p": 0.361,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": -0.14534987029148,
                    "p": 0.30144,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 258.0,
                    "cmap_score": -0.157939952790272,
                    "p": 0.22656,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 142.0,
                    "cmap_score": 0.0981657193320192,
                    "p": 0.48846,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "PC3",
                    "array_platform": "HG-U133A"
                }
            },
            "verapamil": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000556'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00313157'}]",
                    "label_clean": "atrial fibrillation",
                    "prefName": "VERAPAMIL",
                    "targetName": "Voltage-gated L-type calcium channel",
                    "mechanismOfAction": "Voltage-gated L-type calcium channel blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 17.0,
                    "cmap_score": -0.176618535281756,
                    "p": 0.13382,
                    "q": 0.919263931623932,
                    "subset_comparison_id": "filefb07b41e50d_logFC_0",
                    "name": "verapamil",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        },
        "TAHOE": {
            "acetazolamide": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Withdrawn",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02165644'}]",
                    "label_clean": "stroke",
                    "prefName": "ACETAZOLAMIDE",
                    "targetName": "Carbonic anhydrase II",
                    "mechanismOfAction": "Carbonic anhydrase II inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 2488.0,
                    "cmap_score": -0.160394881092933,
                    "p": 0.21625,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "acetazolamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000348",
                    "array_platform": "Tahoe"
                }
            },
            "acetohexamide": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 2613.0,
                    "cmap_score": -0.196619169769909,
                    "p": 0.06871,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "acetohexamide",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000997",
                    "array_platform": "Tahoe"
                }
            },
            "allantoin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 3532.0,
                    "cmap_score": -0.201410003295577,
                    "p": 0.05753,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "allantoin",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000463",
                    "array_platform": "Tahoe"
                }
            },
            "altretamine": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 4238.0,
                    "cmap_score": -0.181462471760126,
                    "p": 0.1168,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "altretamine",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000348",
                    "array_platform": "Tahoe"
                }
            },
            "bergenin": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 8860.0,
                    "cmap_score": -0.183038876707708,
                    "p": 0.11126,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "bergenin",
                    "concentration": 0.0500000007450581,
                    "duration": 24.0,
                    "cell_line": "ACH-000389",
                    "array_platform": "Tahoe"
                }
            },
            "budesonide": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT01257048'}]",
                    "label_clean": "chronic obstructive pulmonary disease",
                    "prefName": "BUDESONIDE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 11092.0,
                    "cmap_score": -0.179651062795714,
                    "p": 0.12335,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "budesonide",
                    "concentration": 5.0,
                    "duration": 24.0,
                    "cell_line": "ACH-000890",
                    "array_platform": "Tahoe"
                }
            },
            "captopril": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT06292091'}\n {'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00223717'}]",
                    "label_clean": "hypertension",
                    "prefName": "CAPTOPRIL",
                    "targetName": "Angiotensin-converting enzyme",
                    "mechanismOfAction": "Angiotensin-converting enzyme inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12233.0,
                    "cmap_score": -0.190563048430551,
                    "p": 0.08588,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "captopril",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000164",
                    "array_platform": "Tahoe"
                }
            },
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12388.0,
                    "cmap_score": -0.168204218670939,
                    "p": 0.17465,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-001190",
                    "array_platform": "Tahoe"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 12693.0,
                    "cmap_score": -0.135679034418247,
                    "p": 0.35863,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "celecoxib",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000669",
                    "array_platform": "Tahoe"
                }
            },
            "ciclopirox": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 13134.0,
                    "cmap_score": -0.208306725528402,
                    "p": 0.04343,
                    "q": 0.996371390541344,
                    "subset_comparison_id": "filefb02324f7b3_logFC_0",
                    "name": "ciclopirox",
                    "concentration": 0.5,
                    "duration": 24.0,
                    "cell_line": "ACH-000139",
                    "array_platform": "Tahoe"
                }
            }
        }
    },
    "Type_2_diabetes": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 279.0,
                    "cmap_score": -0.155656426825444,
                    "p": 0.42165,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 330.0,
                    "cmap_score": -0.188685142363043,
                    "p": 0.27531,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "decitabine": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00042796'}]",
                    "label_clean": "acute promyelocytic leukemia",
                    "prefName": "DECITABINE",
                    "targetName": "DNA (cytosine-5)-methyltransferase 3A",
                    "mechanismOfAction": "DNA (cytosine-5)-methyltransferase 3A inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 328.0,
                    "cmap_score": 0.172637592087946,
                    "p": 0.35086,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "decitabine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.138892330270485,
                    "p": 0.4697,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 403.0,
                    "cmap_score": -0.187792934578228,
                    "p": 0.27976,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 291.0,
                    "cmap_score": 0.203392153600605,
                    "p": 0.2092,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": 0.239213187586447,
                    "p": 0.08837,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "resveratrol": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 227.0,
                    "cmap_score": -0.29013104001082,
                    "p": 0.01704,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "resveratrol",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "rosiglitazone": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00000620'}]",
                    "label_clean": "hypertension",
                    "prefName": "ROSIGLITAZONE",
                    "targetName": "Peroxisome proliferator-activated receptor gamma",
                    "mechanismOfAction": "Peroxisome proliferator-activated receptor gamma agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 95.0,
                    "cmap_score": 0.132201837698623,
                    "p": 0.48182,
                    "q": 0.989856894977169,
                    "subset_comparison_id": "filefb050021acb_logFC_0",
                    "name": "rosiglitazone",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            }
        }
    },
    "Ulcerative_colitis": {
        "CMAP": {
            "carbamazepine": {
                "DrugInfo": {
                    "phase": 2.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00294892'}]",
                    "label_clean": "hiv infection",
                    "prefName": "CARBAMAZEPINE",
                    "targetName": "Sodium channel alpha subunit",
                    "mechanismOfAction": "Sodium channel alpha subunit blocker",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 327.0,
                    "cmap_score": -0.122466168386979,
                    "p": 0.43388,
                    "q": 0.833107929515418,
                    "subset_comparison_id": "filefb06c4562d0_logFC_0",
                    "name": "carbamazepine",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "celecoxib": {
                "DrugInfo": {
                    "phase": 3.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02172040'}]",
                    "label_clean": "hypertension",
                    "prefName": "CELECOXIB",
                    "targetName": "Cyclooxygenase-2",
                    "mechanismOfAction": "Cyclooxygenase-2 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 102.0,
                    "cmap_score": -0.216962615082676,
                    "p": 0.03252,
                    "q": 0.677908,
                    "subset_comparison_id": "filefb06c4562d0_logFC_0",
                    "name": "celecoxib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "clotrimazole": {
                "DrugInfo": {},
                "ExperimentInfo": {
                    "exp_id": 315.0,
                    "cmap_score": -0.112794303781771,
                    "p": 0.46704,
                    "q": 0.845772874493927,
                    "subset_comparison_id": "filefb06c4562d0_logFC_0",
                    "name": "clotrimazole",
                    "concentration": 5e-05,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "dexamethasone": {
                "DrugInfo": {
                    "phase": 0.5,
                    "status": "Recruiting",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT04546126'}]",
                    "label_clean": "hypertension",
                    "prefName": "DEXAMETHASONE",
                    "targetName": "Glucocorticoid receptor",
                    "mechanismOfAction": "Glucocorticoid receptor agonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 40.0,
                    "cmap_score": -0.207924724129721,
                    "p": 0.047,
                    "q": 0.677908,
                    "subset_comparison_id": "filefb06c4562d0_logFC_0",
                    "name": "dexamethasone",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            },
            "fulvestrant": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT02392611'}]",
                    "label_clean": "lymphoma",
                    "prefName": "FULVESTRANT",
                    "targetName": "Estrogen receptor",
                    "mechanismOfAction": "Estrogen receptor antagonist",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 403.0,
                    "cmap_score": -0.204120748524836,
                    "p": 0.05459,
                    "q": 0.677908,
                    "subset_comparison_id": "filefb06c4562d0_logFC_0",
                    "name": "fulvestrant",
                    "concentration": 1e-06,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "gefitinib": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Terminated",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT00087334'}]",
                    "label_clean": "colorectal cancer",
                    "prefName": "GEFITINIB",
                    "targetName": "Epidermal growth factor receptor erbB1",
                    "mechanismOfAction": "Epidermal growth factor receptor erbB1 inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 208.0,
                    "cmap_score": 0.0981843274890293,
                    "p": 0.49334,
                    "q": 0.849641111111111,
                    "subset_comparison_id": "filefb06c4562d0_logFC_0",
                    "name": "gefitinib",
                    "concentration": 1e-05,
                    "duration": 6.0,
                    "cell_line": "HL60",
                    "array_platform": "HG-U133A"
                }
            },
            "oxaprozin": {
                "DrugInfo": {
                    "phase": 4.0,
                    "status": NaN,
                    "urls": "[{'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d958ba-7a60-461b-8622-b73831a00725'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9b0ca6c-4c53-4f6e-918b-02a8c472a194'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e77d2b9e-84df-4733-b654-16e93618efce'}\n {'niceName': 'DailyMed', 'url': 'https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb1c0ab4-a102-46fe-b4cf-0a43fd6d91d9'}]",
                    "label_clean": "rheumatoid arthritis",
                    "prefName": "OXAPROZIN",
                    "targetName": "Cyclooxygenase",
                    "mechanismOfAction": "Cyclooxygenase inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 350.0,
                    "cmap_score": 0.195231545415149,
                    "p": 0.07729,
                    "q": 0.688528235294118,
                    "subset_comparison_id": "filefb06c4562d0_logFC_0",
                    "name": "oxaprozin",
                    "concentration": 0.0003,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HT_HG-U133A_EA"
                }
            },
            "paclitaxel": {
                "DrugInfo": {
                    "phase": 1.0,
                    "status": "Completed",
                    "urls": "[{'niceName': 'ClinicalTrials', 'url': 'https://clinicaltrials.gov/study/NCT03003546'}]",
                    "label_clean": "chronic lymphocytic leukemia",
                    "prefName": "PACLITAXEL",
                    "targetName": "Tubulin",
                    "mechanismOfAction": "Tubulin inhibitor",
                    "drugType": "Small molecule"
                },
                "ExperimentInfo": {
                    "exp_id": 252.0,
                    "cmap_score": -0.0930554520600022,
                    "p": 0.4973,
                    "q": 0.853075889328063,
                    "subset_comparison_id": "filefb06c4562d0_logFC_0",
                    "name": "paclitaxel",
                    "concentration": 1e-07,
                    "duration": 6.0,
                    "cell_line": "MCF7",
                    "array_platform": "HG-U133A"
                }
            }
        }
    }
}